California Fee Petition Mechanics Series
CDPH Licensed Chemical Dependency Recovery Hospital (CDRH)
Health & Safety Code § 1250.3
Attorney Fee Petition Mechanics
How California solo attorneys build and bill CCP § 1021.5 fee petitions in unlicensed Chemical Dependency Recovery Hospital matters — CDPH HFIS license verification, ASAM Criteria for Addictive, Substance-Related, and Co-Occurring Conditions Level 4, NAATP Standards for Member Programs, Ketchum lodestar.
Governing Statute & License Authority
Health & Safety Code § 1250.3 — CDPH Chemical Dependency Recovery Hospital (CDRH) License (California Department of Public Health)
Administered by the California Department of Public Health (CDPH). Primary license verification: CDPH Healthcare Facility Information System (HFIS) at facilities.cdph.ca.gov. Health & Safety Code § 1250.3 (California Health Facility Licensing Law) classifies the Chemical Dependency Recovery Hospital (CDRH) as a distinct licensed hospital type providing 24-hour medically supervised inpatient chemical dependency recovery and detoxification services. The CDPH CDRH license is required for any facility that: (1) provides 24-hour inpatient care to patients undergoing medical detoxification from alcohol, opioids, benzodiazepines, stimulants, or polysubstance dependence requiring physician-directed medical management; (2) administers medications used in medically supervised withdrawal — including benzodiazepines for alcohol withdrawal seizure prevention, buprenorphine or methadone for opioid withdrawal, and clonidine for opioid withdrawal symptom management — in an inpatient setting; (3) provides nursing assessments and medical monitoring for withdrawal complications including delirium tremens (DTs), Wernicke's encephalopathy, seizure risk, and cardiovascular complications; (4) operates under the clinical direction of a physician licensed by the Medical Board of California with documented addiction medicine training or experience. CDPH CDRH license requirements include: a licensed hospital administrator; a medical director who is a California-licensed physician with documented addiction medicine or chemical dependency treatment expertise; California-licensed registered nurses providing 24-hour nursing coverage with patient assessment skills for chemical dependency withdrawal; a clinical treatment program addressing the psychological, social, and vocational dimensions of chemical dependency recovery; written admission criteria aligned with validated patient placement criteria; discharge and transfer planning for each patient; emergency transfer protocols to a general acute care hospital (GACH) for life-threatening withdrawal complications; medication management protocols; CDPH HFIS facility inspection compliance; and Title 22 California Code of Regulations compliance for licensed chemical dependency recovery hospitals.
Section 1250.3 establishes that providing medically supervised inpatient chemical dependency detoxification without an active CDPH CDRH license is unlawful. The endemic unlicensed CDRH pattern includes: (a) former licensed CDRH operators who allow their CDPH license to expire while continuing to admit and treat patients in acute chemical dependency withdrawal — a lapsed CDPH CDRH license makes all continued inpatient treatment unlawful and removes patients from CDPH inspection oversight at the moment they are most medically vulnerable; (b) substance use disorder residential treatment operators (licensed under DHCS §11834.01, not §1250.3) who begin admitting patients in acute medical withdrawal requiring physician-directed inpatient detoxification — DHCS SUD residential licensure does not authorize hospital-level medically managed detoxification; (c) operators establishing unlicensed "medical detox centers" or "medically supervised withdrawal programs" without applying for CDPH CDRH licensure, marketing the facility as clinical detox while lacking physician-directed medical oversight, CDPH-mandated nursing coverage, and emergency transfer infrastructure; (d) operators running facilities that administer controlled substances for withdrawal management without the CDPH CDRH license required to operate the inpatient medical setting in which those medications are dispensed. Patient harm from unlicensed CDRH operation is acute and potentially fatal: patients in alcohol withdrawal can experience seizures and life-threatening delirium tremens; patients in opioid withdrawal face acute medical complications; patients withdrawing from multiple substances simultaneously face compounded risks — all of which require the physician-directed monitoring and emergency response capability that CDPH CDRH licensure mandates.
THE ONLY California CDPH Licensed CDRH § 1250.3 Page in This Series
This is THE ONLY California CDPH Licensed Chemical Dependency Recovery Hospital (CDRH) Health & Safety Code § 1250.3 fee-petition-mechanics page in the ClaimHour fee-petition-mechanics series.
DISTINCT FROM: DHCS Licensed SUD Residential Treatment Program § 11834.01 (DHCS SUD Residential provides 24-hour therapeutic community residential treatment without hospital-level physician-directed medical management; does not require a licensed physician on-site 24 hours; cannot administer controlled substances for acute medical withdrawal management in the inpatient medical context that requires a CDPH CDRH license) / CDPH Licensed General Acute Care Hospital (GACH) § 1250(a) (GACH is a general acute care hospital providing comprehensive inpatient medical services; CDRH is licensed specifically and exclusively for chemical dependency recovery and detoxification — a GACH operating a detox unit without separate CDRH licensure is not operating an unlicensed CDRH; the CDRH license type applies to stand-alone chemical dependency recovery hospitals) / CDPH Licensed Psychiatric Health Facility (PHF) § 1250.2 (PHF provides locked acute inpatient psychiatric care for voluntary and WIC § 5150 involuntary psychiatric holds; PHF licensure does not authorize medical management of acute chemical dependency withdrawal) / DHCS Licensed Opioid Treatment Program (OTP) § 11835 (OTP provides outpatient opioid agonist maintenance treatment with methadone or buprenorphine dispensing; OTP is an outpatient modality, not inpatient 24-hour hospital care; unlicensed OTP operation is a distinct § 11835 violation)
Private Professional Standards Advisories PURE KETCHUM
THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH AN ASAM CRITERIA FOR ADDICTIVE, SUBSTANCE-RELATED, AND CO-OCCURRING CONDITIONS LEVEL 4 ADVISORY
The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions (2023 Edition) — Level 4.0 Medically Managed Intensive Inpatient Treatment
American Society of Addiction Medicine (ASAM) — founded 1954, Chevy Chase, Maryland — the national medical specialty society for physicians specializing in addiction medicine, with over 6,000 physician members including addiction medicine specialists, internal medicine physicians, psychiatrists, and emergency medicine physicians who treat substance use disorders. ASAM's The ASAM Criteria is the most widely used and nationally recognized clinical placement criteria for substance use disorder treatment — used by state licensing agencies, insurance payers, courts, and clinical providers throughout the United States to determine appropriate level of care for patients with substance use disorders. The ASAM Criteria establishes six treatment levels from Level 0.5 (Early Intervention) through Level 4.0 (Medically Managed Intensive Inpatient Treatment), with Level 4.0 representing the hospital-level standard applicable to CDPH-licensed CDRHs. ASAM is DISTINCT from NAATP (American Society of Addiction Medicine is a physician medical specialty society establishing clinical assessment and treatment criteria; NAATP is a provider organization trade association establishing organizational compliance and membership standards for addiction treatment programs — the two cover physician-level clinical standards and organizational program standards from complementary perspectives).
ASAM Criterion A — Active CDPH § 1250.3 CDRH License as Prerequisite for Level 4.0 Medically Managed Intensive Inpatient Treatment: The ASAM Criteria Level 4.0 establishes that medically managed intensive inpatient treatment — the hospital-level care standard — can only be lawfully provided in a facility that holds the appropriate state hospital license for medically supervised 24-hour inpatient chemical dependency recovery and detoxification. In California, that license is the CDPH Chemical Dependency Recovery Hospital license under Health & Safety Code § 1250.3. ASAM Criterion A requirements at Level 4.0 include: (a) physician-directed care: a California-licensed physician with addiction medicine training or experience must serve as medical director and must be available 24 hours for patient medical management decisions — the unlicensed facility that markets itself as a "medically supervised detox center" without a licensed physician available 24 hours falls below the minimum threshold for ASAM Level 4.0 care; (b) facility licensure as a non-negotiable prerequisite: ASAM Criterion A specifies that patient placement into Level 4.0 treatment requires a facility holding the appropriate state license — placing a patient requiring Level 4.0 hospital-level medical management into an unlicensed facility deprives the patient of the regulatory oversight, physician availability, and emergency infrastructure that Level 4.0 requires; (c) 24-hour registered nursing coverage: Level 4.0 requires RN coverage around the clock, with the clinical competency to assess and respond to alcohol withdrawal seizures, opioid withdrawal complications, delirium tremens, and medication-related adverse events; (d) emergency response capability: ASAM Criterion A Level 4.0 requires a written emergency transfer protocol to a GACH for life-threatening complications, with documented physician agreement for emergency transfers and rapid emergency medical services response time.
ASAM Criterion B — Physician-Directed 24-Hour Medical Management with Withdrawal Assessment and Medication Protocols: The ASAM Criteria Level 4.0 Criterion B establishes the physician oversight standards for medically managed inpatient detoxification: (a) admission assessment: each patient admitted to a Level 4.0 CDRH must receive a physician-conducted or physician-supervised admission assessment within the first 24 hours using a validated withdrawal severity assessment tool — the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) for alcohol detoxification; the Clinical Opiate Withdrawal Scale (COWS) for opioid detoxification; or equivalent validated tools appropriate to the substances from which the patient is withdrawing; (b) individualized medical treatment plan: Criterion B requires a written individualized medical treatment plan for each patient, developed by the physician medical director or treating physician within 24 hours of admission, specifying the substances of dependence, withdrawal severity rating, medication protocol, nursing monitoring frequency, and criteria for emergency transfer; (c) medication protocols: Level 4.0 Criterion B requires written facility-level protocols for medication management of acute withdrawal — including benzodiazepine taper protocols for alcohol and sedative-hypnotic withdrawal, opioid agonist protocols for opioid detoxification, and specific dosing guidelines tied to validated withdrawal assessment scores; (d) physician rounding: ASAM Criterion B Level 4.0 requires that each patient be seen by a physician at least once every 24 hours and more frequently if withdrawal severity warrants — all physician assessments must be documented contemporaneously in the patient medical record.
ASAM Criterion F — Patient Placement Criteria and Individualized Discharge/Transfer Planning: Requires that CDRH facilities operating at ASAM Level 4.0: (a) apply the six-dimensional ASAM patient assessment framework to every patient at admission — Dimension 1 (acute intoxication and/or withdrawal potential); Dimension 2 (biomedical conditions and complications); Dimension 3 (emotional, behavioral, or cognitive conditions and complications); Dimension 4 (readiness to change); Dimension 5 (relapse, continued use, or continued problem potential); Dimension 6 (recovery/living environment) — Level 4.0 placement is clinically indicated when Dimension 1 (severe withdrawal risk) and Dimension 2 (serious medical complications) require 24-hour physician-directed medical management; (b) discharge planning initiation within 72 hours: ASAM Criterion F requires that discharge planning begin within 72 hours of admission, identifying the step-down level of care appropriate for the patient following medical stabilization — Level 3.7 (medically monitored intensive inpatient), Level 3.5 (clinically managed residential), or Level 2.1/1.0 (intensive/standard outpatient); (c) transfer protocols: Criterion F requires written procedures for emergency medical transfers to a GACH when Level 4.0 patients develop complications exceeding CDRH clinical capacity; (d) continuing care linkage: Criterion F requires that each discharged patient have a documented referral to or appointment with a continuing care substance use disorder treatment provider appropriate to their post-detox recovery needs.
These are national addiction medicine physician specialty society standards — PURE KETCHUM advisory evidence under Ketchum v. Moses, 24 Cal.4th 1122 (2001) — not independent fee-shifting statutes.
THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH A NAATP STANDARDS FOR MEMBER PROGRAMS ADVISORY
NAATP Standards for Member Programs (2023 Edition)
National Association of Addiction Treatment Providers (NAATP) — founded 1978, Alexandria, Virginia — the national trade association for addiction treatment provider organizations, with over 500 member programs including residential chemical dependency recovery hospitals, therapeutic community programs, intensive outpatient programs, and withdrawal management facilities. NAATP members collectively provide addiction treatment services to hundreds of thousands of patients annually. NAATP's Standards for Member Programs establish the organizational compliance and professional ethics baseline for addiction treatment provider organizations operating at all levels of care, including CDPH-licensed Chemical Dependency Recovery Hospitals at ASAM Level 4.0. NAATP is DISTINCT from ASAM: ASAM (American Society of Addiction Medicine) is a physician medical specialty society publishing clinical assessment criteria that govern physician clinical decision-making about patient placement and treatment protocols; NAATP is an addiction treatment provider trade association publishing organizational standards that govern the operational compliance, ethics, and quality management systems of treatment provider organizations — the two together establish the full clinical and organizational accountability framework for CDPH-licensed CDRH operation.
NAATP Standard 1 — Active CDPH § 1250.3 CDRH License as Prerequisite for All Inpatient Chemical Dependency Treatment Services: NAATP Standard 1 establishes that all NAATP member programs providing residential or inpatient chemical dependency treatment services must hold and maintain the applicable state license for the level of care and setting in which treatment is provided. For NAATP member programs providing medically supervised 24-hour inpatient detoxification in California, Standard 1 requires an active CDPH Chemical Dependency Recovery Hospital license under Health & Safety Code § 1250.3. NAATP Standard 1 requirements include: (a) license maintenance as membership prerequisite: NAATP Standard 1 specifies that maintenance of the applicable state license is a condition of NAATP membership — any member program whose CDPH CDRH license lapses must immediately cease inpatient chemical dependency treatment operations, transfer all patients to licensed facilities, and notify NAATP of the license lapse; continuing inpatient operations with a lapsed CDPH license violates Standard 1 and triggers NAATP membership review; (b) license scope compliance: NAATP Standard 1 requires that all services provided by the member program fall within the scope of the applicable state license — a DHCS-licensed SUD residential program that begins admitting patients requiring physician-directed medical withdrawal management without obtaining a CDPH CDRH license violates Standard 1 by operating a service that exceeds the scope of its DHCS residential license; (c) license posting and disclosure: NAATP Standard 1 requires that the CDPH CDRH license be posted conspicuously in the facility and disclosed to all prospective patients and referring providers; (d) proactive license renewal management: NAATP Standard 1 requires organizational systems for tracking CDPH CDRH license renewal deadlines with sufficient advance notice to ensure no lapse in licensure.
NAATP Standard 4 — Medical Supervision Protocols, Withdrawal Assessment, and Physician Availability: NAATP Standard 4 establishes the medical oversight requirements for NAATP member programs providing inpatient chemical dependency treatment: (a) physician medical director: NAATP Standard 4 requires that every inpatient chemical dependency treatment program maintain a named physician medical director who meets the qualifications for addiction medicine medical direction and who is responsible for the program's medical treatment protocols, physician coverage systems, and clinical quality oversight; (b) withdrawal assessment protocols: Standard 4 requires written clinical protocols for assessment and medical management of acute substance withdrawal, using validated clinical tools (CIWA-Ar for alcohol, COWS for opioids) and specifying medication thresholds and escalation criteria; (c) physician availability: NAATP Standard 4 requires that a physician be on-site or immediately available 24 hours per day for all inpatient programs — the standard distinguishes between "available by phone" (insufficient for Level 4.0) and "on-site or immediately available" (required for medically managed inpatient detox); (d) nursing assessment documentation: Standard 4 requires nursing withdrawal assessments to be documented every four hours at minimum for patients in active withdrawal, with more frequent documentation when CIWA-Ar or COWS scores warrant heightened monitoring; (e) medication management records: NAATP Standard 4 requires contemporaneous documentation of all medications administered, including the clinical indication, dose, route, time of administration, and administering provider.
NAATP Standard 7 — Clinical Outcome Documentation, Ethics, and Patient Rights: Requires NAATP member programs to: (a) patient rights disclosure: each patient admitted to a NAATP member CDRH must receive a written patient rights disclosure within 24 hours of admission specifying their right to receive care in a licensed facility, their right to informed consent for all medications and procedures, and their right to contact CDPH to verify the facility's license status; (b) outcomes documentation: NAATP Standard 7 requires that each CDRH maintain documentation of patient treatment outcomes, including completion of medically supervised detoxification without adverse events, transfer rates to higher levels of care, and referral to continuing care; (c) ethics compliance: Standard 7 requires that NAATP member programs adhere to the Ethical Principles and Standards of the addiction treatment field — including prohibitions on patient solicitation, kickbacks for patient referrals, and unlicensed clinical practice; (d) complaint resolution: NAATP Standard 7 requires a documented patient grievance process, including a mechanism for patients to report concerns about facility licensing, clinical care quality, or staff conduct; (e) adverse event reporting: Standard 7 requires reporting of serious adverse events to CDPH in compliance with mandatory reporting timeframes — including patient deaths, serious injuries, or events requiring emergency transfer during inpatient chemical dependency treatment.
These are national addiction treatment provider organization trade association standards — PURE KETCHUM advisory evidence — not independent fee-shifting statutes.
TWO PRIVATE STANDARDS ON ONE PAGE: ASAM Criteria for Addictive, Substance-Related, and Co-Occurring Conditions Level 4.0 (2023 Edition) + NAATP Standards for Member Programs (2023 Edition) — both PURE KETCHUM, both first-in-series.
CCP § 1021.5 Fee-Shifting Framework
California Code of Civil Procedure § 1021.5 authorizes attorney fee awards when: (1) the action results in enforcement of an important right affecting the public interest; (2) a significant benefit is conferred on the general public; and (3) the necessity and financial burden of private enforcement justify fee-shifting. Unlicensed chemical dependency recovery hospital enforcement satisfies all three prongs: patients undergoing acute medical withdrawal from alcohol, opioids, benzodiazepines, or polysubstance dependence are in a medically vulnerable state requiring physician-directed care — a state in which they cannot meaningfully evaluate whether the facility they are in holds the CDPH license necessary for their safety. Unlicensed CDRH operators who admit patients in acute withdrawal without CDPH licensing, physician oversight, validated withdrawal protocols, and emergency transfer infrastructure expose patients to preventable seizures, cardiovascular events, delirium tremens, and death without any regulatory mechanism for oversight or accountability. Protection of chemically dependent patients from unlicensed hospital-level treatment facilities is a significant public benefit justifying CCP § 1021.5 fee-shifting.
Ketchum Lodestar Calculation
Under Ketchum v. Moses, 24 Cal.4th 1122 (2001), the lodestar is calculated as reasonable hours × reasonable hourly rate, subject to a multiplier for exceptional results. PLCM Group Inc. v. Drexler, 22 Cal.4th 1084 (2000), establishes the prevailing market rate standard. Hensley v. Eckerhart, 461 U.S. 424 (1983), requires documentation of all hours reasonably expended. Missouri v. Jenkins, 491 U.S. 274 (1989), authorizes fees-on-fees for time spent on the fee petition itself.
ASAM Criteria + NAATP Standards as PURE KETCHUM Lodestar Evidence
Both the ASAM Criteria Level 4.0 and NAATP Standards for Member Programs are private professional association standards — they do not create independent statutory fee-shifting. Their role under Ketchum is as advisory evidence establishing: (a) the physician-level clinical treatment baseline (ASAM Criteria A/B/F) and the addiction treatment organizational compliance baseline (NAATP Standards 1/4/7) that CDPH-licensed CDRH operators must maintain; (b) the specific violations committed by the unlicensed operator — no CDPH license, no physician medical director, no validated withdrawal protocols, no emergency transfer infrastructure; and (c) the public benefit of enforcement protecting patients in acute chemical dependency withdrawal from unlicensed facilities without physician oversight or CDPH accountability. This is the PURE KETCHUM posture: addiction medicine clinical standards (ASAM) and addiction treatment organizational standards (NAATP) as lodestar evidence from two distinct accountability dimensions — not independent fee triggers.
CDPH CDRH License Verification — Welch Anchor
Under Welch v. Metropolitan Life Ins. Co., 480 F.3d 942 (9th Cir. 2007), fee petitions require a declaration establishing prevailing market rate supported by evidence. In § 1250.3 unlicensed CDRH matters, the primary Welch anchor is the CDPH Healthcare Facility Information System (HFIS) at facilities.cdph.ca.gov — confirming no active CDPH CDRH license for the facility address, or a license that was expired or lapsed during the period of unlicensed chemical dependency inpatient treatment. CDPH investigation records, patient census records, withdrawal incident documentation (or its absence), physician oversight documentation (or its absence), medication administration records, ASAM patient placement assessments (or their absence), and GACH emergency transfer records establish the specific harm elements for each unlicensed CDRH matter.
Frequently Asked Questions
- What California statute governs Chemical Dependency Recovery Hospital licensing and when does unlicensed CDRH operation trigger CCP § 1021.5?
- Health & Safety Code § 1250.3 (administered by CDPH) requires an active CDPH license for any facility providing medically supervised 24-hour inpatient chemical dependency recovery and detoxification. Unlicensed CDRH operation may support CCP § 1021.5 fee-shifting when enforcement protects patients in acute medical withdrawal from unlicensed facilities lacking physician-directed care, CDPH safety oversight, and validated withdrawal management protocols.
- Does a DHCS SUD Residential license authorize admitting patients in acute medical withdrawal requiring physician-directed inpatient detoxification?
- No. A DHCS Licensed Substance Use Disorder Residential Treatment Program license under § 11834.01 authorizes 24-hour therapeutic community residential treatment. DHCS SUD Residential licensure does not authorize physician-directed medical management of acute chemical dependency withdrawal — including administering benzodiazepines for alcohol withdrawal seizure prevention or buprenorphine for opioid withdrawal in an inpatient medical context. A DHCS-licensed SUD residential facility that admits patients in severe alcohol or opioid withdrawal requiring medication-assisted medically supervised detoxification is operating a service that requires a separate CDPH CDRH license under § 1250.3.
- How does the ASAM Criteria Level 4.0 serve as PURE KETCHUM advisory evidence in a § 1250.3 fee petition?
- The ASAM Criteria Level 4.0 (2023 Edition) — published by ASAM (founded 1954, Chevy Chase MD, 6,000+ addiction medicine physicians) — establishes the national physician-level clinical standard for medically managed intensive inpatient treatment: active CDPH §1250.3 CDRH license as prerequisite for Level 4.0 treatment (Criterion A), physician-directed 24-hour withdrawal assessment and medication protocols (Criterion B), and patient placement criteria and discharge/transfer planning (Criterion F). The ASAM Criteria is PURE KETCHUM advisory evidence — national addiction medicine physician society clinical standards, not independent fee-shifting statutes.
- How does NAATP Standards for Member Programs serve as PURE KETCHUM advisory evidence?
- NAATP Standards for Member Programs (2023 Edition) — published by NAATP (founded 1978, Alexandria VA, 500+ addiction treatment provider member programs) — establishes the addiction treatment organizational compliance baseline: active CDPH §1250.3 CDRH license as prerequisite for all inpatient chemical dependency services (Standard 1), medical supervision protocols and withdrawal assessment requirements (Standard 4), and outcome documentation and patient rights (Standard 7). NAATP Standards are PURE KETCHUM advisory evidence — DISTINCT from ASAM Criteria (ASAM = physician clinical placement standards; NAATP = provider organization compliance standards).
- What is the estimated annual billing gap for a solo attorney handling § 1250.3 unlicensed CDRH matters?
- The estimated billing gap is 13.25 hours: Gap 1 (CDPH HFIS license verification; ASAM Criteria A/B/F review; NAATP Standards 1/4/7 review; client intake; §1250.3 analysis; patient census; physician credential records; withdrawal assessment review; medication records; emergency incident documentation — 5.25 hrs); Gap 2 (Ketchum memo; PLCM rate analysis; CCP §1021.5 public benefit analysis; patient harm quantification; withdrawal severity documentation; fee petition draft — 4.00 hrs); Gap 3 (Welch declaration; CDPH HFIS records; ASAM and NAATP standards exhibits; patient census; physician credential absence; withdrawal protocol absence; emergency records; hearing prep — 4.00 hrs). At $300–$500/hr: $3,975–$6,625 per matter — billable time ClaimHour captures automatically without manual entry.